Patents Assigned to ASTRAZENECA AB GLOBAL INTELLECTUAL PROPERTY
  • Publication number: 20090221576
    Abstract: New use of 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile as a free base or a pharmaceutically acceptable salt thereof, in a method of prevention and/or treatment of bone-related disorders, osteoporosis, increasing bone formation or increasing bone mineral density.
    Type: Application
    Filed: January 31, 2007
    Publication date: September 3, 2009
    Applicant: ASTRAZENECA AB GLOBAL INTELLECTUAL PROPERTY
    Inventors: Anna-Lena Berg, Ratan Bhat